Question 1

What is Jonathan Javitt?

Accepted Answer

Jonathan Javitt is a Person.

Question 2

How often does Jonathan Javitt appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Jonathan Javitt first tracked by Ergen?

Accepted Answer

First tracked on Apr 15, 2026.

Question 4

When was Jonathan Javitt last mentioned in news?

Accepted Answer

Last active on Jun 25, 2026.

Question 5

What is Jonathan Javitt's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Jonathan Javitt in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Jonathan Javitt?

Accepted Answer

HOPE Therapeutics deploys Zeta TMS (Jun 25, 2026, 6 articles).

Question 8

How did the "HOPE Therapeutics deploys Zeta TMS" event impact Jonathan Javitt?

Accepted Answer

Jonathan Javitt, as Chairman and CEO of NRx Pharmaceuticals and MiNK Therapeutics, provided a statement on the significance of treating the first patients with the Zeta TMS Navigation System.

Question 9

How did the "NRx Pharmaceuticals Incorporates Defense Subsidiary" event impact Jonathan Javitt?

Accepted Answer

Dr. Jonathan Javitt, founder and Chairman of NRx Pharmaceuticals, brings extensive health and defense-related R&D experience to the new subsidiary.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.